SS31
SS31 is a mitochondrial-targeting peptide explored in research involving mitochondrial function, oxidative stress and cellular energetics.
Research overview
SS-31, also known in clinical research as elamipretide, is a mitochondria-targeting tetrapeptide. Research has examined interactions with mitochondrial membranes and cardiolipin, bioenergetics and oxidative-stress pathways.
Evidence status
SS-31/elamipretide has been studied in human trials as well as experimental models. Results differ across diseases and endpoints, so mechanistic promise should not be presented as universal clinical efficacy.
Areas under investigation
- Mitochondrial membrane biology
- Cardiolipin-associated mechanisms
- Bioenergetics and oxidative-stress research
Explore the scientific literature
For primary-source reading, search the indexed biomedical literature and registered clinical studies. These links are provided as research gateways rather than endorsements of any particular finding.